Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod in High-grade Cervical Intraepithelial Lesions
NCT06356012Phase 4Recruiting
- Sponsor
- Hospital de Amor
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of imiquimod in Squamous Intraepithelial Lesion (SIL), sponsored by Hospital de Amor. Started Apr 2024; status: recruiting.
02
Drugs
imiquimod
03
Conditions
Squamous Intraepithelial Lesion (SIL)
Beyond the preview
Go deeper on NCT06356012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06356012.